Efficacy of atenolol to prevent perioperative hypertension in hypertensive patients underwent endoscopic cholecystectomy
DOI:
https://doi.org/10.5281/zenodo.8148463Keywords:
laparoscopic cholecystectomy, hypertension, atenolol, perioperative medicineAbstract
Introduction: perioperative hypertension represents one of the leading alterations detected performing endoscopic cholecystectomy. It is presumed that atenolol has a protective effect able to reduce this morbid condition, likely due to its beta-blocking action.
Objective: to assess the efficacy of atenolol on preventing perioperative hypertension performing laparoscopic cholecystectomy in the surgical unit of the Hospital Clínico Quirúrgico "Lucía Íñiguez Landín" of Holguín, Cuba.
Method: an observational, analytical, longitudinal and prospective cohort study was conducted with two study groups at the same time, experimental group and control group, from January to December, 2018. A total of 697 patients (N=697) evaluated in the preoperative consultation were involved in the study, the sample included 183 hypertensive patients (n=183) who underwent endoscopic surgery for gallbladder lithiasis, of whom 95 were randomized to the atenolol treatment group and 88 to the control group. Patients in the treatment group were administered atenolol at 25 mg daily for 15 days before surgery. Leading variables used were systolic, diastolic and mean arterial pressures, and specific indicators were used to evaluate treatment effectiveness.
Results: preoperative arterial pressures decreased significantly with the use of atenolol in the treatment group. Perioperative hypertension was more frequent in the control group. Atenolol is a selective beta 1 receptor blocker, who causes a hypertensive effects in the central level, depressing the bulbar vasomotor center.
Conclusion: the results of this investigation show that the use of atenolol in treatment was an effective alternative, thus effectiveness reduce perioperative hypertension rate.
Downloads
References
2. Registros Médicos y Estadísticas de Salud. Anuario Estadístico de Salud 2017 [Internet]. La Habana: Ministerio de Salud Pública; 2018. [citado 22 Jun 2023]; Disponible en: https://salud.msp.gob.cu/wp-content/Anuario/anuario_2017_edici%C3%B3n_2018.pdf
3. Jacomelli Ramos LP, Barcello Araújo R, Valente Castro MC do, Seravelli Ramos MRM, Cunha-e-Silva JA, Iglesias AC. Hemodynamic evaluation of elderly patients during laparoscopic cholecystectomy. Rev Col Bras Cir [Internet]. 2018 [citado 22 Jun 2023]; 45(2):1-7. DOI: https://doi.org/10.1590/0100-6991e-20181659
4. Amores Agulla T, Marrero Quesada JÁ, García Somoza J. Repercusión de la colecistectomía laparoscópica en el paciente geriátrico. Rev Hab Cienc Méd [Internet]. 2018. [citado 22 Jun 2023]; 17(6):931-42. Disponible en: https://revhabanera.sld.cu/index.php/rhab/article/view/2314
5. Purizaga Carranza PA. Variabilidad hemodinámica en colecistectomía laparoscópica con anestesia espinal en el Hospital Regional Docente II-2 “José Alfredo. [Tesis Médico Cirujano]. Perú: Universidad Cesar Vallejo, Facultad de Ciencias de la Salud; 2018 [citado 22 Jun 2023]. Disponible en: https://hdl.handle.net/20.500.12692/25757
6. Osorio Bedoya E, Amariles P. Hipertensión arterial en pacientes de edad avanzada: una revisión estructurada. Rev Colomb Card [Internet]. 2018 [citado 22 Jun 2023]; 25(3):209-221. Disponible en: https://doi.org/10.1016/j.rccar.2017.10.006
7. Teixido-Tura G, Rodríguez-Palomares J, González Mirelis J, Gutiérrez García-Moreno L, Sánchez V, Galian Gay L, et al. 5034-3 - Eficacia a largo plazo del atenolol comparado con losartan para la prevención de la dilatación aórtica y las complicaciones aórticas en el síndrome de marfan. Rev Esp Cardiol [Internet]. 2018 [citado 22 Jun 2023]; 71(Supl 1):624. Disponible en: https://www.revespcardiol.org/es-congresos-sec-2018-el-congreso-76-sesion-cardiologia-clinica-miscelanea-4387-eficacia-largo-plazo-del-atenolol-51691-pdf
8. Hazzi R, Mayock R. Perioperative management of hypertension. J Xiangya Med [Internet]. 2018 [citado 22 Jun 2023]; 3(6):1-25. Disponible en: https://jxym.amegroups.org/article/view/4570/5371
9. Poldermans D, Bax JJ, Boersma E, De Hert S, Eeckhout E, Fowkes G, et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J [Internet]. 2009 [citado 22 Jun 2023]; 30(22):2769-812. DOI: https://doi.org/10.1093/eurheartj/ehp337
10. WMA - The World Medical Association – Principios éticos para las investigaciones médicas en seres humanos; 2018 [citado 22 Jun 2023]. Disponible en: https://www.wma.net/es/policies-post/declaracion-de-helsinki-de-la-amm-principios-eticos-para-las-investigaciones-medicas-en-seres-humanos/
11. Cáceres Figueroa LA, Martínez Félix JI, Prince Angulo SA, Arce Bojórquez B, Dehesa López E, Peraza Garay FJ. Eficiencia de los antihipertensivos como premedicación en colecistectomía laparoscópica de urgencia. Rev Med Uas [Internet]. 2018 [citado 22 Jun 2023]; 8(2):1-10. Disponible en: https://hospital.uas.edu.mx/revmeduas/pdf/v8/n2/antihipertensivos.pdf
12. Zaidel E. Fármacos antianginosos mucho más allá de los nitritos. Farmacol Cardiov [Internet]. 2018 [citado 22 Jun 2023]. Disponible en: https://www.siacardio.com/academia/farmacologia/farmacos-antianginosos-mucho-mas-alla-de-los-nitritos/
